Patents by Inventor Terry Patrick Lebold

Terry Patrick Lebold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CASEIN KINASE 1 DELTA MODULATORS
    Publication number: 20230339970
    Abstract: A compound of Formula (I), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with casein kinase 1 delta (CSNK1D) modulation, such as those associated with mood/psychiatric disorders, neurodegenerative diseases, cancers, addiction and substance abuse disorders, pain, and metabolic diseases. Wherein R1, R2, R3, and R4, are defined herein.
    Type: Application
    Filed: September 16, 2021
    Publication date: October 26, 2023
    Inventors: Terry Patrick Lebold, Cathy Preville, Andrew V. Samant, Brock T. Shireman, Luke Edward Hanna, Mark Seierstad, Stefan McCarver, Dongpei Wu, Kelsey Patrick, Elizabeth Swift
  • CASEIN KINASE 1 DELTA MODULATORS
    Publication number: 20230339900
    Abstract: A compound of Formula (I) or Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with casein kinase 1 delta (CSNK1D) modulation, such as those associated with mood/psychiatric disorders, neurodegenerative diseases, cancers, addiction and substance abuse disorders, pain, and metabolic diseases. Wherein R1, R2, R3, R4, R1a, R2a, R3, and R4a are defined herein.
    Type: Application
    Filed: September 16, 2021
    Publication date: October 26, 2023
    Inventors: Terry Patrick Lebold, Stefan McCarver, Kelly J. McClure, Cathy Preville, Mark Seierstad, Brock T. Shireman, Jocelyn Wang, Dongpei Wu, Wei Zhang, Jeannie M. Ziff
  • AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
    Publication number: 20210284641
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Application
    Filed: May 19, 2021
    Publication date: September 16, 2021
    Applicant: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Cynthia G.B. Berry, Gang Chen, Fabrice Loic Jourdan, Terry Patrick Lebold, David Wei Lin, Miguel Angel Pena Piñon, Suohitra Ravula, Bradley M. Savall, Devin M. Swanson, Dongpei Wu, Wei Zhang
  • Fused azaheterocyclic compounds and their use as AMPA receptor modulators
    Patent number: 10155769
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: December 18, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Brian Ngo Laforteza, Terry Patrick Lebold, Suchitra Ravula, Brad M. Savall, Brock T. Shireman
  • Fused bicylic pyridine compounds and their use as AMPA receptor modulators
    Patent number: 10087185
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: October 2, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Márió Gyuris, Brian Ngo Laforteza, Terry Patrick Lebold, Stephen Todd Meyer, Suchitra Ravula, Brad M. Savall, Brock T. Shireman, Warren Stanfield Wade, János Gerencsér
  • AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
    Publication number: 20180118740
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Application
    Filed: April 28, 2016
    Publication date: May 3, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Cynthia G. B. Berry, Gang Chen, Fabrice Loic Jourdan, Terry Patrick Lebold, David Wei Lin, Miguel Angel Pena Piñon, Suchitra Ravula, Bradley M. Savall, Devin M. Swanson, Dongpei Wu, Wei Zhang
  • FUSED AZAHETEROCYCLIC COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS
    Publication number: 20180111942
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Application
    Filed: October 23, 2017
    Publication date: April 26, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Brian Ngo Laforteza, Terry Patrick Lebold, Suchitra Ravula, Brad M. Savall, Brock T. Shireman
  • FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS
    Publication number: 20180111933
    Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).
    Type: Application
    Filed: October 23, 2017
    Publication date: April 26, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Michael K. Ameriks, Márió Gyuris, Brian Ngo Laforteza, Terry Patrick Lebold, Stephen Todd Meyer, Suchitra Ravula, Brad M. Savall, Brock T. Shireman, Warren Stanfield Wade, János Gerencsér